Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DDIT3 (7G7) Mouse Monoclonal Antibody

Product Specifications

Background

Inhibits the DNA-binding activity of C/EBP and LAP by forming heterodimers that cannot bind DNA.

Product Name Alternative

DDIT3; CHOP; CHOP10; GADD153; DNA damage-inducible transcript 3 protein; DDIT-3; C/EBP-homologous protein; CHOP; C/EBP-homologous protein 10; CHOP-10; Growth arrest and DNA damage-inducible protein GADD153

Gene Name

DDIT3

Gene ID

1649

Swiss Prot

P35638

Host

Mouse

Reactivity

Human, Rat, Mouse

Clonality

Monoclonal

Conjugation

Unconjugated

Applications

WB, IHC, ICC/IF

Field of Research

Epigenetics and Nuclear Signaling

Purification

Affinity Purification

Dilution

WB 1:500-1:1000, IHC 1:50-1:100, ICC/IF 1:50-1:200

Form

Liquid

Buffer

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

Modification

Unmodified

Molecular Weight

Calculated MW: 19 kDa; Observed MW: 27 kDa

Storage Conditions

Store at 4°C short term. Aliquot and store at -20°C for 12 months. Avoid freeze/thaw cycles.

Isotype

IgG1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PSMC3IP (NM_013290) Human Over-expression Lysate
LY415686 100 µg

PSMC3IP (NM_013290) Human Over-expression Lysate

Ask
View Details
Lentiviral human IFNGR1 shRNA (UAS) - Lentiviral human IFNGR1 shRNA (UAS, RFP) (25)
GTR15312146 1 Vial

Lentiviral human IFNGR1 shRNA (UAS) - Lentiviral human IFNGR1 shRNA (UAS, RFP) (25)

Ask
View Details
C8orf33 (UPF0488 Protein C8orf33, FLJ20989) (FITC)
124160-FITC 100 µL

C8orf33 (UPF0488 Protein C8orf33, FLJ20989) (FITC)

Ask
View Details
Anti-Human CD154 Recombinant Antibody (Letolizumab)
YR1450-01 1 mg

Anti-Human CD154 Recombinant Antibody (Letolizumab)

Ask
View Details
Anti-Human CD154 Recombinant Antibody (Letolizumab)
YR1450-02 5 mg

Anti-Human CD154 Recombinant Antibody (Letolizumab)

Ask
View Details